These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2173517)
21. [Potential antineoplastics. III: N-mustard derivatives of diethylstilbestrol and hexestrol with free phenolic hydroxy groups (author's transl)]. Hamacher H Arch Pharm (Weinheim); 1978 Mar; 311(3):184-95. PubMed ID: 655784 [No Abstract] [Full Text] [Related]
22. Hexestrol-linked cytotoxic agents: synthesis and binding affinity for estrogen receptors. Köhle H; Krohn K; Leclercq G J Med Chem; 1989 Jul; 32(7):1538-47. PubMed ID: 2544725 [TBL] [Abstract][Full Text] [Related]
23. Quantitative structure-activity relationship study on hexestrol and metahexestrol derivatives interacting with estrogen receptors. Gupta SP; Handa A Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):357-66. PubMed ID: 3033781 [TBL] [Abstract][Full Text] [Related]
24. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor. Teutsch G; Goubet F; Battmann T; Bonfils A; Bouchoux F; Cerede E; Gofflo D; Gaillard-Kelly M; Philibert D J Steroid Biochem Mol Biol; 1994 Jan; 48(1):111-9. PubMed ID: 8136296 [TBL] [Abstract][Full Text] [Related]
25. Anticancer drugs: estrophilic cisplatin derivatives. Engel J; Schönenberger H; Lux F; Hilgard P Cancer Treat Rev; 1987 Dec; 14(3-4):275-83. PubMed ID: 2830970 [TBL] [Abstract][Full Text] [Related]
26. Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs. Katzenellenbogen JA; Carlson KE; Heiman DF; Goswami R J Nucl Med; 1980 Jun; 21(6):550-8. PubMed ID: 6247466 [TBL] [Abstract][Full Text] [Related]
27. Sensitivity of a Tier I screening battery compared to an in utero exposure for detecting the estrogen receptor agonist 17 beta-estradiol. O'Connor JC; Frame SR; Biegel LB; Cook JC; Davis LG Toxicol Sci; 1998 Aug; 44(2):169-84. PubMed ID: 9742655 [TBL] [Abstract][Full Text] [Related]
28. Carcinogenicity and metabolic activation of hexestrol. Liehr JG; Ballatore AM; Dague BB; Ulubelen AA Chem Biol Interact; 1985 Oct; 55(1-2):157-76. PubMed ID: 2998630 [TBL] [Abstract][Full Text] [Related]
33. [Synthesis of 3,3'disubstituted hexestrol derivatives and their binding affinity to cytoplasmatic estrogen receptors (author's transl)]. Hamacher H Arch Pharm (Weinheim); 1981 Jul; 314(7):631-44. PubMed ID: 6271092 [No Abstract] [Full Text] [Related]
34. Potential estrogenic and antiandrogenic effects of permethrin in rats. Kim SS; Lee RD; Lim KJ; Kwack SJ; Rhee GS; Seok JH; Lee GS; An BS; Jeung EB; Park KL J Reprod Dev; 2005 Apr; 51(2):201-10. PubMed ID: 15599112 [TBL] [Abstract][Full Text] [Related]
35. Conformational analysis of nonsteroidal estrogens: The effect of conformer populations on the binding affinity of meso- and dl-hexestrol to the estrogen receptor. Kilbourn MR; Arduengo AJ; Park JT; Katzenellenbogen JA Mol Pharmacol; 1981 May; 19(3):388-98. PubMed ID: 6267445 [No Abstract] [Full Text] [Related]
36. The oestrogenic potency in the mouse of several substances closely related to diethylstilboestrol and meso-hexoestrol. Miller BG; Emmens CW J Endocrinol; 1969 Sep; 45(1):9-15. PubMed ID: 5347383 [No Abstract] [Full Text] [Related]
37. Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881). van Roijen JH; Ooms MP; Weber RF; Brinkmann AO; Grootegoed JA; Vreeburg JT J Androl; 1997; 18(1):51-61. PubMed ID: 9089068 [TBL] [Abstract][Full Text] [Related]
38. [Uterine response of golden hamsters to estrogenic stimulation in postnatal ontogeny]. Loktionov AS Ontogenez; 1980; 11(5):501-10. PubMed ID: 6255391 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. O'Connor JC; Davis LG; Frame SR; Cook JC Toxicol Sci; 2000 Apr; 54(2):338-54. PubMed ID: 10774816 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent. Shani J; Gazit A; Livshitz T; Biran S J Med Chem; 1985 Oct; 28(10):1504-11. PubMed ID: 2995668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]